Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-027214
Filing Date
2018-05-10
Accepted
2018-05-10 17:27:36
Documents
2
Period of Report
2018-06-07
Effectiveness Date
2018-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv493448_def14a.htm DEF 14A 423568
2 GRAPHIC tv493448_img1.jpg GRAPHIC 84027
  Complete submission text file 0001144204-18-027214.txt   540738
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32295 | Film No.: 18824177
SIC: 2836 Biological Products, (No Diagnostic Substances)